FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

11804411000001100: Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
43130801000001115 Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43130901000001114 Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Is pack of Co-beneldopa 25mg/100mg/5ml oral suspension false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has active ingredient Benserazide false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has active ingredient Benserazide hydrochloride false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has VMP Co-beneldopa 25mg/100mg/5ml oral suspension true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has specific active ingredient Benserazide hydrochloride true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Has basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Co-beneldopa 25mg/100mg/5ml oral suspension (Special Order) 1 ml Is a True Co-beneldopa 25mg/100mg/5ml oral suspension 1 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start